Emerging impact of triazoles as anti-tubercular agent

A Sharma, AK Agrahari, S Rajkhowa… - European Journal of …, 2022 - Elsevier
Tuberculosis, a disease of poverty is a communicable infection with a reasonably high
mortality rate worldwide. 10 Million new cases of TB were reported with approx 1.4 million …

Isocyanide based [4+ 1] cycloaddition reactions: an indispensable tool in multi-component reactions (MCRs)

T Kaur, P Wadhwa, S Bagchi, A Sharma - Chemical Communications, 2016 - pubs.rsc.org
The advent of cycloaddition reactions in the synthesis of heterocycles and their ever
burgeoning applications in the fields of material chemistry, catalysis and drugs have been a …

Coumarin–triazole hybrids and their biological activities

YL Fan, X Ke, M Liu - Journal of Heterocyclic Chemistry, 2018 - Wiley Online Library
Hybridization is emerged as a promising strategy in the discovery of new drugs, especially
these with complimentary activities and multiple pharmacological targets that are the …

Targeting DNA replication and repair for the development of novel therapeutics against tuberculosis

MA Reiche, DF Warner, V Mizrahi - Frontiers in molecular …, 2017 - frontiersin.org
Mycobacterium tuberculosis is the etiological agent of tuberculosis (TB), an infectious
disease which results in approximately 10 million incident cases and 1.4 million deaths …

One pot Click chemistry: A three component reaction for the synthesis of 2-mercaptobenzimidazole linked coumarinyl triazoles as anti-tubercular agents

A Anand, MV Kulkarni, SD Joshi, SR Dixit - Bioorganic & Medicinal …, 2016 - Elsevier
Propargylthiobenzimidazole 1, 4-bromomethyl coumarins/1-aza-coumarins 2/3 and sodium
azide have been reacted in one pot under Click chemistry conditions to give exclusively 1, 4 …

Targeting bacterial topoisomerases: how to counter mechanisms of resistance

YC Tse-Dinh - Future Medicinal Chemistry, 2016 - Taylor & Francis
DNA gyrase and topoisomerase IV are type IIA bacterial topoisomerases that are targeted by
highly effective antibiotics. However, resistance via multiple mechanisms arises to limit the …

Target-based approaches for the discovery of new antimycobacterial drugs

C Borsari, S Ferrari, A Venturelli, MP Costi - Drug Discovery Today, 2017 - Elsevier
Highlights•The most recently studied drug targets are reviewed.•The protein–protein
interaction network was generated using STRING database.•Hits and leads were discovered …

Versatility of 7-substituted coumarin molecules as antimycobacterial agents, neuronal enzyme inhibitors and neuroprotective agents

E Kapp, H Visser, SL Sampson, SF Malan… - Molecules, 2017 - mdpi.com
A medium-throughput screen using Mycobacterium tuberculosis H37Rv was employed to
screen an in-house library of structurally diverse compounds for antimycobacterial activity. In …

Embryonic and larval zebrafish models for the discovery of new bioactive compounds against TB

SS Antunes, G Forn-Cuní, NC Romeiro, HP Spaink… - Drug Discovery …, 2024 - Elsevier
TB is a world health challenge the treatment of which is impacted by the rise of drug-
resistant strains. Thus, there is an urgent need for new antitubercular compounds and novel …

Chemical classes targeting energy supplying GyrB domain of Mycobacterium tuberculosis

A Kashyap, PK Singh, O Silakari - Tuberculosis, 2018 - Elsevier
Tuberculosis (TB) is contagious in nature and immunocompromised patients have a higher
probability of developing TB. The occurrence of drug resistance, has led to serious health …